Evidence map›Paper›PMID 39650619›Full record

ArticleNanoscale advances2025

Protein corona formation on different-shaped CdSe/CdS semiconductor nanocrystals.

Kunisato Kuroi, Yuta Kanazawa, Akane Shinaridome, Yuna Yasuda, Minkyo Jung, Chan-Gi Pack, Fumihiko Fujii

Abstract read
In one paragraph

Article in Nanoscale advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kunisato KuroiFaculty of Pharmaceutical Sciences, Kobe Gakuin University Kobe 650-8586 Japan kkuroi@pharm.kobegakuin.ac.jp fumihiko.fujii@pharm.kobegakuin.ac.jp.ORCID https://orcid.org/0000-0002-5889-2334
Yuta KanazawaFaculty of Pharmaceutical Sciences, Kobe Gakuin University Kobe 650-8586 Japan kkuroi@pharm.kobegakuin.ac.jp fumihiko.fujii@pharm.kobegakuin.ac.jp.
Akane ShinaridomeFaculty of Pharmaceutical Sciences, Kobe Gakuin University Kobe 650-8586 Japan kkuroi@pharm.kobegakuin.ac.jp fumihiko.fujii@pharm.kobegakuin.ac.jp.
Yuna YasudaFaculty of Pharmaceutical Sciences, Kobe Gakuin University Kobe 650-8586 Japan kkuroi@pharm.kobegakuin.ac.jp fumihiko.fujii@pharm.kobegakuin.ac.jp.
Minkyo JungNeural Circuit Research Group, Korea Brain Research Institute Daegu 41062 Korea.ORCID https://orcid.org/0000-0002-3288-3288
Chan-Gi PackConvergence Medicine Research Center (CREDIT), Asan Institute for Life Sciences, Asan Medical Center Seoul 05505 Korea.ORCID https://orcid.org/0000-0002-6578-3099
Fumihiko FujiiFaculty of Pharmaceutical Sciences, Kobe Gakuin University Kobe 650-8586 Japan kkuroi@pharm.kobegakuin.ac.jp fumihiko.fujii@pharm.kobegakuin.ac.jp.ORCID https://orcid.org/0000-0001-8382-8919

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanoparticles (NPs) have been widely studied and applied in medical and pharmaceutical fields. When NPs enter the

Identifiers

PMID39650619
PMCPMC11621831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.